CoChat

Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: a meta-analysis of randomized controlled trials.

Open access

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 15 of the 52 sources its claims cite were checked for support.

Abstract

The aim of this meta-analysis was to explore the efficacy of a ketogenic diet in metabolic control in patients with overweight or obesity and with or without type 2 diabetes. Embase, PubMed, and Cochrane Library were searched for randomized controlled trials that enrolled patients with overweight or obesity on a ketogenic diet for metabolic control. Fourteen studies were included in meta-analysis. The effects of ketogenic diets on glycemic control were greater for diabetic patients relative to those of low-fat diets, indicated by lower glycated hemoglobin (SMD, −0.62; p < 0.001) and homeostatic model assessment index (SMD, −0.29; p = 0.02), while comparable effects were observed for nondiabetic patients. Ketogenic diets led to substantial weight reduction (SMD, −0.46; p = 0.04) irrespective of patients’ diabetes status at baseline and improved lipid profiles in terms of lower triglyceride (SMD, −0.45; p = 0.01) and greater high-density lipoprotein (SMD, 0.31; p = 0.005) for diabetic patients. Other risk markers showed no substantial between-group difference post intervention. Our study findings confirmed that ketogenic diets were more effective in improving metabolic parameters associated with glycemic, weight, and lipid controls in patients with overweight or obesity, especially those with preexisting diabetes, as compared to low-fat diets. This effect may contribute to improvements in metabolic dysfunction-related morbidity and mortality in these patient populations.

Overview

CoChat Summary

TL;DR

This meta-analysis of 14 RCTs found that ketogenic diets improved glycemic control, weight loss, and some lipid parameters in patients with overweight/obesity, especially those with preexisting type 2 diabetes, compared with low-fat-based comparator diets. Effects on blood pressure, CRP, and serum creatinine were comparable to comparator diets.

Key findings

  • In diabetic patients, ketogenic diets lowered HbA1c (SMD, −0.62; 95% CI, −0.89 to −0.35; p < 0.001; I² = 0%) and HOMA index (SMD, −0.29; 95% CI, −0.54 to −0.04; p = 0.02; I² = 0%) versus comparator diets; nondiabetic patients showed no significant glycemic decrease.
  • Overall, ketogenic diets lowered fasting glucose (SMD, −0.25; 95% CI, −0.50 to −0.00; I² = 52%) and HbA1c (SMD, −0.48; 95% CI, −0.69 to −0.27; I² = 23%); mean between-group HbA1c changes were −0.5% in diabetic patients and −0.42% overall (both p < 0.001).
  • Weight reduction was greater with ketogenic diets (SMD, −0.46; 95% CI, −0.90 to −0.03; I² = 78%); mean between-group weight changes were −7.78 kg in diabetic patients and −3.81 kg overall. BMI and waist circumference reductions approached but did not reach significance (p = 0.08 and p = 0.09).
  • In diabetic patients, ketogenic diets lowered triglycerides (SMD, −0.45; 95% CI, −0.80 to −0.10; I² = 59%) and raised HDL (SMD, 0.31; 95% CI, 0.10 to 0.52; I² = 0%); in nondiabetic patients, total cholesterol (SMD, 0.34; 95% CI, 0.08 to 0.61) and LDL (SMD, 0.35; 95% CI, 0.09 to 0.61) increased. Other risk markers showed no substantial between-group difference.

Methods

  • PRISMA-guided systematic review and meta-analysis; Embase, PubMed, and Cochrane Library searched through 11 February 2020 for RCTs of ketogenic diets in patients with overweight or obesity, with or without type 2 diabetes, versus comparator diets (primarily low-fat-based).
  • Fourteen RCTs were included, enrolling 734 participants: 444 diabetic patients and 290 nondiabetic patients; intervention durations varied across outcomes (e.g., 3–12 months for glycemic control, 4 weeks–12 months for weight, and 4 days–2 years for lipids).
  • Continuous outcomes were pooled as weighted standardized mean differences with 95% CIs; fixed- or random-effects models were chosen based on I²; subgroup analyses were performed by baseline type 2 diabetes status; RevMan 5.3 was used, with Cochrane risk-of-bias and GRADE assessments and Begg’s/Egger’s tests for publication bias.

Limitations

  • The paper states that included RCTs had different study designs and control diets (mostly low-fat-based), intervention durations varied, some subgroup analyses may have been underpowered due to small sample size, and surrogate markers were used rather than patient-important endpoints such as cardiovascular/renal events or mortality.
  • Evident from the text: only one included study reported adverse effects; two studies had high risk of attrition bias and one had high risk of bias from baseline triglyceride imbalance; heterogeneity was high for weight (I² = 78%) and triglycerides (I² = 59%).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu12072005

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Figures

Figure 1 Study selection diagram. Abbreviation: RCT, randomized controlled trial.
Figure 1 Study selection diagram. Abbreviation: RCT, randomized controlled trial.CC BY · PubMed Central
Figure 2 Risk of bias summary.
Figure 2 Risk of bias summary.CC BY · PubMed Central
Figure 3 Forest plots for association between glycemic control and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in fasting glucose; (b) changes in HbA1c; (c) changes in fasting insulin; (d) changes in C-peptide; (e) changes in HOMA. Abbreviations: CI, confidence interval; DM, diabetes mellitus; Non-DM, non-diabetes mellitus; HbA1c, glycated hemoglobin; HOMA, homeostatic model assessment; T2DM, type 2 diabetes mellitus.
Figure 3 Forest plots for association between glycemic control and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in fasting glucose; (b) changes in HbA1c; (c) changes in fasting insulin; (d) changes in C-peptide; (e) changes in HOMA. Abbreviations: CI, confidence interval; DM, diabetes mellitus; Non-DM, non-diabetes mellitus; HbA1c, glycated hemoglobin; HOMA, homeostatic model assessment; T2DM, type 2 diabetes mellitus.CC BY · PubMed Central
Figure 4 Forest plots for association between weight control and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in body weight; (b) changes in BMI; (c) changes in waist circumference. Abbreviations: CI, confidence interval; BMI, body mass index; T2DM, type 2 diabetes mellitus.
Figure 4 Forest plots for association between weight control and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in body weight; (b) changes in BMI; (c) changes in waist circumference. Abbreviations: CI, confidence interval; BMI, body mass index; T2DM, type 2 diabetes mellitus.CC BY · PubMed Central
Figure 5 Forest plots for association between lipid control and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in total cholesterol; (b) changes in triglyceride; (c) changes in LDL; (d) changes in HDL. Abbreviations: CI, confidence interval; DM, diabetes mellitus; Non-DM, non-diabetes mellitus; LDL, low-density lipoprotein; HDL, high-density lipoprotein; T2DM, type 2 diabetes mellitus.
Figure 5 Forest plots for association between lipid control and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in total cholesterol; (b) changes in triglyceride; (c) changes in LDL; (d) changes in HDL. Abbreviations: CI, confidence interval; DM, diabetes mellitus; Non-DM, non-diabetes mellitus; LDL, low-density lipoprotein; HDL, high-density lipoprotein; T2DM, type 2 diabetes mellitus.CC BY · PubMed Central
Figure 6 Forest plots for association between other risk markers and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in systolic blood pressure; (b) changes in diastolic blood pressure; (c) changes in C-reactive protein; (d) changes in serum creatinine. Abbreviations: CI, confidence interval; T2DM, type 2 diabetes mellitus.
Figure 6 Forest plots for association between other risk markers and ketogenic diet in patients with overweight or obesity and with or without T2DM: (a) Changes in systolic blood pressure; (b) changes in diastolic blood pressure; (c) changes in C-reactive protein; (d) changes in serum creatinine. Abbreviations: CI, confidence interval; T2DM, type 2 diabetes mellitus.CC BY · PubMed Central

Verification

Claims the paper makes

9 Valid · 0 Not valid · 21 Not checked · 70 Own results and interpretations

53 more claims

Create a free account to see all 100 claims and to verify the 37 references still open.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 24

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Research works printed but not linked: 1

  1. Osler, 1923, Diabetes mellitus, The Principles and Practice of Medicine, Volume 1, 421

Cited by

See all 193

Metadata

Authors
Choi, Y. J., Jeon, S.-M., & Shin, S.
Affiliations
  • Hallym University Medical Center (KR)
  • Ajou University (KR)
Corresponding author
Shin, Sooyoung
Venue
Nutrients
Publisher
MDPI AG
Published
2020-07-06
Volume
12
Issue
7
Pages
2005
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3038345563
Cited by
193
References
64
Citations by year
2026: 19 · 2025: 32 · 2024: 40 · 2023: 46 · 2022: 40 · 2021: 14 · 2020: 2
FWCI
3.25
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Research Foundation
  • Ajou University
  • Korea Health Industry Development Institute (HI17C0640)
  • National Research Foundation of Korea (2017R1C1B5015912)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
ketogenic diet, obesity, overweight, type 2 diabetes, glycemic control, HbA1c, HOMA-IR, weight loss, lipid profile, triglycerides, HDL cholesterol, metabolic parameters
MeSH terms
Adolescent, Adult, Aged, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Female, Humans, Lipids, Male, Middle Aged, Obesity, Randomized Controlled Trials as Topic, Overweight, Diet, Ketogenic, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.